logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kenji Sawa

osaka metropolitan university
H指数:13
被引数:2,752

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer
BRITISH JOURNAL OF CANCER
IF6.8
2024-03-220
PRE
Haratani, Koji; Nakamura, Atsushi; Mamesaya, Nobuaki; Sawa, Kenji; Shiraishi, Yoshimasa; Saito, Ryota; Tanizaki, Junko; Tamura, Yosuke; Hata, Akito; Tsuruno, Kosuke; Sakamoto, Tomohiro; Teraoka, Shunsuke; Oki, Masahide; Watanabe, Hiroshi; Tokito, Takaaki; Nagata, Kenji; Masuda, Takeshi; Nakamura, Yasushi; Sakai, Kazuko; Chiba, Yasutaka; Ito, Akihiko; Nishio, Kazuto; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Hayashi, Hidetoshi
Comparison of the specimen quality of endobronchial ultrasound-guided intranodal forceps biopsy using standard-sized forceps versus mini forceps for lung cancer: A prospective study
RESPIROLOGY
IF6.3
2024-01-213
PRE
Nakai, Toshiyuki; Matsumoto, Yuji; Ueda, Takahiro; Kuwae, Yuko; Tanaka, Sayaka; Miyamoto, Atsushi; Matsumoto, Yoshiya; Sawa, Kenji; Sato, Kanako; Yamada, Kazuhiro; Watanabe, Tetsuya; Asai, Kazuhisa; Furuse, Hideaki; Uchimura, Keigo; Imabayashi, Tatsuya; Uenishi, Riki; Fukui, Mitsuru; Tanaka, Hidenori; Ohsawa, Masahiko; Kawaguchi, Tomoya; Tsuchida, Takaaki
Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-12-010
OA
Tanizaki, Junko; Kuroda, Hiroaki; Yokoyama, Toshihide; Takahama, Makoto; Shoda, Hiroyasu; Nakamura, Atsushi; Kitamura, Yoshitaka; Mamesaya, Nobuaki; Kadota, Yoshihisa; Sawa, Kenji; Okishio, Kyoichi; Okada, Morihito; Suminaka, Chihiro; Noda, Kenta; Sakai, Kazuko; Chiba, Yasutaka; Nishio, Kazuto; Chamoto, Kenji; Honjo, Tasuku; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Hayashi, Hidetoshi
NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study
MOLECULAR ONCOLOGY
IF4.5
2023-10-283
OA
Ikeda, Satoshi; Tsuboi, Masahiro; Sakai, Kazuko; Misumi, Toshihiro; Akamatsu, Hiroaki; Shoda, Hiroyasu; Sakakura, Noriaki; Nakamura, Atsushi; Ohde, Yasuhisa; Hayashi, Hidetoshi; Okishio, Kyoichi; Okada, Morihito; Yoshino, Ichiro; Okami, Jiro; Takahashi, Kazuhisa; Ikeda, Norihiko; Tanahashi, Masayuki; Tambo, Yuichi; Saito, Haruhiro; Toyooka, Shinichi; Inokawa, Hidetoshi; Chen-Yoshikawa, Toyofumi; Yokoyama, Toshihide; Okamoto, Tatsuro; Yanagitani, Noriko; Oki, Masahide; Takahama, Makoto; Sawa, Kenji; Tada, Hirohito; Nakagawa, Kazuhiko; Mitsudomi, Tetsuya; Nishio, Kazuto

研究方向

暂未获取到该数据
T
Tomoya Kawaguchi
H 指数:46论文数:438被引数:1.0万
Y
Yoshiya Matsumoto
H 指数:10论文数:92被引数:327
H
Hiroyasu Kaneda
H 指数:35论文数:260被引数:5,925
Y
Yoko Tani
H 指数:7论文数:71被引数:243
S
Shigeki Mitsuoka
H 指数:16论文数:102被引数:880
T
Tetsuya Watanabe
H 指数:38论文数:542被引数:6,906
K
Kazuhisa Asai
H 指数:25论文数:167被引数:2,313
K
Koichi Ogawa
H 指数:8论文数:45被引数:269
M
Motohiro Izumi
H 指数:7论文数:45被引数:233
N
Nobuyuki Yamamoto
H 指数:73论文数:1,055被引数:2.9万